ENSC — Ensysce Biosciences, Inc.

ENSCEnsysce Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · ensysce.com

0.2969USD-6.93%Mkt Cap: 4.39M USDP/E: —Last update: 2026-05-26

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activa…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap4.39M USD

Enterprise Value3.92M USD

Revenue (TTM)4.71M USD

Gross Profit-5.67M USD

Net Income (TTM)-10.18M USD

Revenue/Share1.202 USD

Last Price0.2969 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees8

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.14

PEG—

EV/EBITDA—

EV/Revenue0.83

P/S1.01

P/B-8.73

EPS (TTM)-3.11

EPS (Forward)-2.23

52W Range

0.23003% of range2.750

52W High2.750 USD

52W Low0.2300 USD

Profitability

Gross Margin-120.42%

Oper. Margin-370.68%

EBITDA Margin0.00%

Profit Margin-250.36%

ROE-316.63%

ROA-136.54%

Growth

Revenue Growth-27.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-7.81M USD

CapEx (TTM)123.64K USD

FCF Margin-116.85%

FCF Yield-125.38%

Net Debt-499.63K USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.10

Current Ratio0.71

Quick Ratio0.26

Book Value/Sh-0.0370 USD

Cash/Share0.0510 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:15

Split DateDec 6, 2024

Analyst Consensus

Rating0.0 (Hold)

Target (Mean)16.45 USD

Target Range16.45 USD – 16.45 USD

# Analysts1

Ownership

Shares Out.14.69M

Float14.68M

Insiders0.07%

Institutions3.31%

Short Interest

Short Ratio0.2d

Short % Float0.57%

Short % Out.0.57%

Shares Short52.73K

Short (prev mo.)194.92K

Technical

SMA 500.4505 (-34.1%)

SMA 2001.278 (-76.8%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)3.61M

Avg Vol (10d)10.26M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—